Skip to content

Drug interactions

Avapritinib + Crizotinib

Severity: Major

Avapritinib and Crizotinib: major interaction.

Last updated Sources: Health Canada product monograph

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib is a moderate CYP3A4 inhibitor and may raise avapritinib exposure. This may increase avapritinib toxicities such as cognitive effects, intracranial hemorrhage and edema.

What this interaction means in plain words

Avapritinib and Crizotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Crizotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Crizotinib inhibits CYP3A4, reducing avapritinib clearance.

What to do

Avoid the combination; if unavoidable, reduce the avapritinib dose per labeling and monitor for neurologic and bleeding adverse effects.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avapritinib and Crizotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Avapritinib with Crizotinib?

MediHelp rates the interaction as major. Avapritinib and Crizotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Crizotinib is a moderate CYP3A4 inhibitor and may raise avapritinib exposure. This may increase avapritinib toxicities such as cognitive effects, intracranial hemorrhage and edema.

How serious is the interaction between Avapritinib and Crizotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; if unavoidable, reduce the avapritinib dose per labeling and monitor for neurologic and bleeding adverse effects.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in